UBS lowers ORCL target to $245 from $285UBS 下调目标价 甲骨文 (ORCL)：$285 → $245
Price Target Revision
UBS lowered its price target for Oracle Corporation (ORCL) to $245 from $285 on August 6, 2026, a 14.0% downward adjustment. The software infrastructure giant, with a current market capitalization of $415.9 billion, traded at $144.36 in pre-market hours that day, down 0.94% from the prior session. The revision only adjusted the price target, with no accompanying change to the firm’s stock rating for Oracle.
Analyst Sentiment Context
This adjustment represents a single firm’s narrowed valuation outlook for Oracle, reflecting UBS’s revised expectation of the company’s 12-month intrinsic value. Concurrent Benzinga reporting on the same day noted that Oracle’s recent debt-funded AI expansion has widened its credit default swap (CDS) spreads, a factor likely incorporated into the bank’s valuation model for this revision.
Cross-Referenced Independent Signal
A verifiable public data point for context comes from Form 4 insider filings: on June 26, 2026, Oracle Vice Chairman Jeffrey Henley sold ~443,000 company shares across multiple on-market trades, with execution prices ranging from $156.06 to $162.99, generating over $57.9 million in total proceeds. Additionally, the December 31, 2025 13F institutional holdings report showed Oracle’s institutional float ownership at 43.7%, with 1,561 institutional funds reducing their positions, outpacing the 419 funds that opened new positions.
Follow-Up Markers and Signal Boundaries
This adjustment solely reflects UBS’s independent valuation judgment, not a universal market consensus. The signal does not incorporate Oracle’s upcoming quarterly earnings report scheduled for September 8, 2026, nor the company’s subsequent AI business deployment progress. This signal is not an investment recommendation, and does not constitute a basis for buying, selling, or holding Oracle stock.
股价目标价调整
瑞银（UBS）于2026年8月6日将甲骨文公司（ORCL）的股价目标价从285美元下调至245美元，下调幅度达14.0%。这家市值4159亿美元的软件基础设施巨头当日盘前股价报144.36美元，较前一交易日下跌0.94%。本次调整仅涉及目标价修正，未同步调整对甲骨文的股票评级。
分析师情绪解读
此次调整属于单一券商的估值预期收窄，反映UBS对甲骨文未来12个月内在价值的判断下调。结合同日Benzinga的报道，甲骨文近期为AI业务扩张举债推高了其信用利差，这一因素可能被纳入了本次目标价下调的模型考量。
交叉参考独立信号
可对照的公开数据包括：2026年6月26日，甲骨文副董事长Jeffrey Henley通过多笔场内交易合计出售约44.3万股公司股票，成交价格区间为156.06美元至162.99美元，总募资额超5790万美元。此外，2025年12月31日的13F机构持仓报告显示，甲骨文机构流通股持仓占比为43.7%，1561家机构减持头寸，多于新增持仓的419家机构。
后续关注与信号边界
本次调整仅为UBS的独立估值判断，不代表全市场统一观点。该信号未覆盖甲骨文将于2026年9月8日发布的下一季度财报数据，也未纳入公司后续AI业务的具体落地进展。本信号并非投资建议，不构成任何买卖或持有股票的依据。
This analysis was generated by InvestLog AI based on SEC filings, Form 4 insider transactions, Form 144 planned-sale notices, 13F institutional holdings, analyst ratings, and market data. It is for informational purposes only and does not constitute investment advice.这篇研究由 InvestLog AI 基于 SEC 披露、Form 4 内部人交易、Form 144 计划减持、13F 机构持仓、分析师评级和市场数据生成。内容仅供参考，不构成投资建议。